Unlock stock picks and a broker-level newsfeed that powers Wall Street.
6.21
-0.51
(-7.59%)
At close: April 3 at 4:00:01 PM EDT
5.99
-0.22
(-3.54%)
Pre-Market: 6:06:17 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
135,436
135,436
121,139
104,952
105,339
Cost of Revenue
54,317
54,317
48,144
60,159
45,784
Gross Profit
81,119
81,119
72,995
44,793
59,555
Operating Expense
133,735
133,735
117,658
119,501
116,076
Operating Income
-52,616
-52,616
-44,663
-74,708
-56,521
Net Non Operating Interest Income Expense
14,655
14,655
15,839
5,131
-403
Other Income Expense
-136
-136
1,189
-29,833
1,340
Pretax Income
-38,097
-38,097
-27,635
-99,410
-55,584
Tax Provision
434
434
719
164
-36
Net Income Common Stockholders
-38,531
-38,531
-28,354
-99,574
-55,548
Diluted NI Available to Com Stockholders
-38,531
-38,531
-28,354
-99,574
-55,548
Basic EPS
-1.00
--
-0.75
-2.61
-1.60
Diluted EPS
-1.00
--
-0.75
-2.61
-1.60
Basic Average Shares
38,367
--
37,594
36,990.97
36,000
Diluted Average Shares
38,367
--
37,594
36,990.97
36,000
Total Operating Income as Reported
-52,616
-52,616
-45,991
-104,264
-56,521
Rent Expense Supplemental
3,020
3,020
3,712
1,411
--
Total Expenses
188,052
188,052
165,802
179,660
161,860
Net Income from Continuing & Discontinued Operation
-38,531
-38,531
-28,354
-99,574
-55,548
Normalized Income
-38,531
-38,531
-27,304.88
-76,224.76
-55,548
Interest Income
14,655
14,655
15,839
5,131
--
Net Interest Income
14,655
14,655
15,839
5,131
-403
EBIT
-52,616
-52,616
-44,663
-74,708
-56,521
EBITDA
-44,260
-44,260
-36,373
-68,584
-51,641
Reconciled Cost of Revenue
54,317
54,317
48,144
60,159
45,784
Reconciled Depreciation
8,356
8,356
8,290
6,124
4,880
Net Income from Continuing Operation Net Minority Interest
-38,531
-38,531
-28,354
-99,574
-55,548
Total Unusual Items Excluding Goodwill
--
--
-1,328
-29,556
--
Total Unusual Items
--
--
-1,328
-29,556
--
Normalized EBITDA
-44,260
-44,260
-35,045
-39,028
-51,641
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
--
--
-278.88
-6,206.76
--
12/31/2021 - 12/7/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CVRX CVRx, Inc.
12.27
-5.47%
CTKB Cytek Biosciences, Inc.
3.7200
-6.77%
LAB Standard BioTools Inc.
1.0700
-9.32%
TCMD Tactile Systems Technology, Inc.
13.63
-1.66%
ICAD iCAD, Inc.
1.8500
-5.13%
SGHT Sight Sciences, Inc.
2.2300
-0.89%
NPCE NeuroPace, Inc.
13.01
-3.91%
CLPT ClearPoint Neuro, Inc.
12.14
-7.30%
QDEL QuidelOrtho Corporation
32.49
-6.18%
CERS Cerus Corporation
1.2900
-7.86%